[{"address1": "2000 Sierra Point Parkway", "address2": "Suite 400", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "415 798 8589", "website": "https://www.tempesttx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-mediated mechanisms to treat various tumors. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, which is in a Phase 1 trial to treat cancer; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial for the treatment of solid tumors. It also develops TREX-1, an enzyme that regulates cGAS/STING pathway signaling and immune recognition. The company has agreement with Roche to advance the evaluation of amezalpat (TPST-1120) in combination with atezolizumab (Tecentriq\u00ae) and bevacizumab. Tempest Therapeutics, Inc. was incorporated in 2011 and is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.", "fullTimeEmployees": 17, "companyOfficers": [{"maxAge": 1, "name": "Mr. Stephen R. Brady J.D., LLM", "age": 54, "title": "CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 923235, "exercisedValue": 0, "unexercisedValue": 262204}, {"maxAge": 1, "name": "Mr. Nicholas  Maestas", "age": 43, "title": "CFO, Head of Corporate Strategy & Secretary", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 465429, "exercisedValue": 0, "unexercisedValue": 67328}, {"maxAge": 1, "name": "Dr. Samuel  Whiting M.D., Ph.D.", "age": 57, "title": "Executive VP, Chief Medical Officer and Head of R&D", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 667651, "exercisedValue": 0, "unexercisedValue": 93438}, {"maxAge": 1, "name": "Mr. Justin  Trojanowski CPA", "age": 36, "title": "Corporate Controller, Treasurer & Principal Accounting Officer", "yearBorn": 1988, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lindsay  Young", "title": "Head of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.9322, "open": 0.94, "dayLow": 0.91, "dayHigh": 0.94, "regularMarketPreviousClose": 0.9322, "regularMarketOpen": 0.94, "regularMarketDayLow": 0.91, "regularMarketDayHigh": 0.94, "beta": -2.659, "forwardPE": -0.8455455, "volume": 736197, "regularMarketVolume": 736197, "averageVolume": 1396072, "averageVolume10days": 1045260, "averageDailyVolume10Day": 1045260, "bid": 0.896, "ask": 0.9626, "bidSize": 200, "askSize": 200, "marketCap": 40591520, "fiftyTwoWeekLow": 0.699, "fiftyTwoWeekHigh": 6.0, "fiftyDayAverage": 0.88416, "twoHundredDayAverage": 1.62188, "currency": "USD", "enterpriseValue": 36213492, "floatShares": 40048147, "sharesOutstanding": 43642100, "sharesShort": 2599503, "sharesShortPriorMonth": 2597274, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0596, "heldPercentInsiders": 0.0016500001, "heldPercentInstitutions": 0.13675, "shortRatio": 2.06, "shortPercentOfFloat": 0.064899996, "impliedSharesOutstanding": 43740600, "bookValue": 0.431, "priceToBook": 2.1580048, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -35518000, "trailingEps": -1.53, "forwardEps": -1.38, "lastSplitFactor": "1:15", "lastSplitDate": 1624838400, "enterpriseToEbitda": -1.029, "52WeekChange": -0.74810815, "SandP52WeekChange": 0.22903383, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "TPST", "underlyingSymbol": "TPST", "shortName": "Tempest Therapeutics, Inc.", "longName": "Tempest Therapeutics, Inc.", "firstTradeDateEpochUtc": 1352730600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "d54d822e-cd83-39cb-b46d-5c9b6edb9502", "messageBoardId": "finmb_552715229", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.9301, "targetHighPrice": 47.0, "targetLowPrice": 5.0, "targetMeanPrice": 18.75, "targetMedianPrice": 11.5, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 22116000, "totalCashPerShare": 0.507, "ebitda": -35197000, "totalDebt": 17738000, "quickRatio": 1.583, "currentRatio": 1.686, "debtToEquity": 154.822, "returnOnAssets": -0.77007, "returnOnEquity": -6.9188704, "freeCashflow": -17905500, "operatingCashflow": -29053000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]